Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Daniela Teferici (Albania): “Heart Failure is the world's leading heart failure congress, where everyone in our community can be updated with the new strategies for the prevention and treatment of heart failure, a disease with which we have so much to do in our daily practice. I think this is the biggest benefit of attending this congress. Also, the World Congress on Acute Heart Failure taking part in Europe is a big advantage for us: it is more reachable, so we can be in touch with the latest news also from other continents.”
Oswald Londono (Barcelona): “The biggest benefit from attending the congress is the positive impact on the life of my patients. I like to hear new experiences of my colleagues: new ideas always appear.”
Mohammad El Tahlawi (Egypt): “Heart Failure & World Congress on Acute heart Failure is a good opportunity to meet the experts, exchange the knowledge, network with your peers, update yourself and present your work in this scientific community. I, myself was very interested to participate in this event as I am finishing an e-book about the heart failure in pediatric populations and was eager to update my knowledge about this field of science.”
Olga Dzhioeva (Russian Federation): “My motivation to attend the congress is the problem of Heart failure itself. We have a lot of information and can succefully treat ischemic heart deaseses, arrythmias, but we have a lot of questions about heart failure. It is very useful to participate in the congress, especially as a young participant.”
Juste Maneikytė (Lithuania): “Heart failure medication treatment adherence to ESC guidelines in Lithuania was my thesis for graduating medical school. I had an outstanding mentor who encouraged me to submit an abstract for the Heart Failure 2016. It was a great opportunity to share our knowledge and best practices of our clinic with other professionals. Connecting through shared experiences in medical practice is one of essential ways of learning and improving as a specialist.”
Lidija Savic (Serbia): “I work in the coronary care unit and in my everyday clinical practice I often treat patients with acute heart failure complicating acute coronary syndrome. So for me, the biggest benefit is to learn new things about treatment of acute heart failure. Heart Failure brings the latest updates in this field. Other benefits of attending this congress is updating my knowledge in treating patients with heart failure and various comorbidities.”
Nikolay Ilov (Russian Federation): “Today, a cardiologist is a specialist who has to be competent in different fields of internal and interventional medicine. A great amount of scientific and educational events are held over the world to solve this complicated problem. All specialists and researchers deal with the question of choosing which congress to visit. I chose Heart Failure 2016 because I wanted to be heard and to hear thousands of colleagues representing different countries and sub-specialties. The biggest benefit of attending this congress was an opportunity to have conversations with them and to get knowledge for my everyday practice.”
Ercole Vellone (Italy): “I think the biggest benefit of attending Heart Failure is to meet people across the world who are studying your same topic. When you see other investigators and clinicians with whom you can share the same problems, everything becomes easier! This is very important for the best of our patients!”
Alberto Palazzuoli (Italy): “Professional training and knowledge improvement is the key asset for any good doctor and I do believe that this congress can be a great opportunity to this purpose. It will give me the chance to share knowledge and experience with some of the most prominent cardiologists in the world, as well as the opportunity to learn and strengthen my knowledge on the latest breakthrough discoveries in my field of expertise.I also believe that the congress is an important platform to reinforce professional bonds that will allow the planning of future clinical trials in which my medical centre could be involved.”
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.